RU2001124532A - A method for the treatment of nephrolithiasis - Google Patents

A method for the treatment of nephrolithiasis

Info

Publication number
RU2001124532A
RU2001124532A RU2001124532/14A RU2001124532A RU2001124532A RU 2001124532 A RU2001124532 A RU 2001124532A RU 2001124532/14 A RU2001124532/14 A RU 2001124532/14A RU 2001124532 A RU2001124532 A RU 2001124532A RU 2001124532 A RU2001124532 A RU 2001124532A
Authority
RU
Russia
Prior art keywords
stage
pentoxifylline
drug therapy
nephrolithiasis
treatment
Prior art date
Application number
RU2001124532/14A
Other languages
Russian (ru)
Other versions
RU2225175C2 (en
Inventor
Иван Алексеевич Бобровский
Виталий Александрович Гройсман
Original Assignee
Городская больница № 1 г. Тольятти
Filing date
Publication date
Application filed by Городская больница № 1 г. Тольятти filed Critical Городская больница № 1 г. Тольятти
Priority to RU2001124532/14A priority Critical patent/RU2225175C2/en
Priority claimed from RU2001124532/14A external-priority patent/RU2225175C2/en
Publication of RU2001124532A publication Critical patent/RU2001124532A/en
Application granted granted Critical
Publication of RU2225175C2 publication Critical patent/RU2225175C2/en

Links

Claims (1)

Способ лечения нефролитиаза, включающий дооперационный этап, дистанционную литотрипсию и послеоперационный этап, на каждом из которых пациента подвергают медикаментозной терапии, причем медикаментозную терапию на дооперационном и послеоперационном этапе выполняют путем приема в организм фармакологической композиции, включающей α-токоферол ацетата и пентоксифиллин, отличающийся тем, что в фармакологическую композицию введены эскузан, тимусамин, вазаламини ренисамин, при этом компоненты находятся в следующем соотношении, вес. ч.:A method for the treatment of nephrolithiasis, including the preoperative stage, remote lithotripsy and the postoperative stage, at each of which the patient is subjected to drug therapy, and drug therapy at the preoperative and postoperative stage is performed by taking a pharmacological composition comprising α-tocopherol acetate and pentoxifylline, characterized in that that escusan, thymusamine, vasalamini renisamine are introduced into the pharmacological composition, while the components are in the following ratio, weight. hours: Пентоксифиллин 40Pentoxifylline 40 Эскузан 25Aescusan 25 α-токоферол 10α-tocopherol 10 Тимусамин 2Thymusamine 2 Вазаламин 2Vasalamin 2 Ренисамин 2Renisamine 2 а на этапе дистанционной литотрипсии медикаментозную терапию выполняют путем введения инфузионного раствора, содержащего 800-1200 мл 0,9%-ного изотонического раствора хлорида натрия и 5 мл (100 мг) пентоксифиллина.and at the stage of remote lithotripsy, drug therapy is performed by administering an infusion solution containing 800-1200 ml of 0.9% isotonic sodium chloride solution and 5 ml (100 mg) of pentoxifylline.
RU2001124532/14A 2001-09-03 2001-09-03 Method for treating nephrolithiasis RU2225175C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001124532/14A RU2225175C2 (en) 2001-09-03 2001-09-03 Method for treating nephrolithiasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001124532/14A RU2225175C2 (en) 2001-09-03 2001-09-03 Method for treating nephrolithiasis

Publications (2)

Publication Number Publication Date
RU2001124532A true RU2001124532A (en) 2003-06-10
RU2225175C2 RU2225175C2 (en) 2004-03-10

Family

ID=32390063

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001124532/14A RU2225175C2 (en) 2001-09-03 2001-09-03 Method for treating nephrolithiasis

Country Status (1)

Country Link
RU (1) RU2225175C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2687593C1 (en) * 2018-08-02 2019-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Западный государственный медицинский университет им. И.И. Мечникова" Министерства здравоохранения Российской Федерации Method of treating nephrolithiasis patients with dense stones
RU2704022C1 (en) * 2019-01-09 2019-10-23 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method of proteomic correction of oxalate nephrolithiasis

Similar Documents

Publication Publication Date Title
RU2220143C2 (en) Optically active derivatives of benzopyrane, pharmaceutical composition based on thereof and method for treatment of estrogen-sensitive diseases
EP1171121B1 (en) Pharmaceutical compositions comprising dipeptidylpeptidase iv inhibitors for the promotion of growth
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
RU2006141647A (en) DERIVATIVES OF PHENOXIAL ALKALBONIC ACIDS IN THE TREATMENT OF INFLAMMATORY DISEASES
CA1078736A (en) Therapeutic application of 4-carbamoyl-5-hydroxyimidazole
CA2290446A1 (en) Method and compositions for administering taxanes orally to human patients
JPS63270626A (en) Antiulcer agent
BR0015149A (en) Method and compositions for administering taxanes orally to human patients
TR200101163T2 (en) Bile water substituted phenyl-alkenoylguanidines, production methods, uses
RU2004131214A (en) METHODS FOR TREATING COGNITIVE DISORDERS
RU2005105691A (en) Oral Administration of Calcitonin
RU2001124532A (en) A method for the treatment of nephrolithiasis
JPH04312527A (en) Method of treating hepatic inssuficiency and liver disease
WO2007086395A1 (en) Photodynamic therapy kit
KR100816140B1 (en) Use of a vitamin combination for the treatment of primary headaches
GB2189703A (en) Vinpocetine
JPS63198630A (en) Lipid metabolism improver
RU2001113211A (en) METHOD FOR TREATMENT OF ACUTE ABSTINENT SYNDROME OF PATIENTS WITH ADDICTION
RU2002113978A (en) A method of stimulating motor activity of the intestine
JPH11130672A (en) Lipid peroxidation inhibitor
SU1445728A1 (en) Method of treatment of hypertension
MD1568G2 (en) Method of treatment of the burn disease in the burn shock period
RU2006138043A (en) METHOD FOR TREATING A STROKE USING DEFIBRINOGENIZING AGENTS TO ACHIEVE THE SPECIFIC CHARACTER OF DEFIBRINOGENIZATION
SU1097333A1 (en) Method of treatment of hypertension
RU2336878C2 (en) Medication for erectile disfunction treatment